In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDRH budget

This article was originally published in The Gray Sheet

Executive Summary

House votes 378 to 46 in favor of proposed Center for Devices & Radiological Health fiscal 2007 budget of $228.8 mil. on May 23 as part of the "Agriculture, Rural Development, Food & Drug Administration, and Related Agencies Appropriations Act, 2007." Despite shaving $476,000 off the President's request, the figure passed is still sufficient to enable the MDUFMA user fee program, FDA says. The bill will be reconciled with upcoming legislation in the Senate...

You may also be interested in...



CDRH budget

Senate Appropriations Committee votes June 22 to report the fiscal year 2007 appropriations bill for the "Department of Agriculture, Rural Development, Food & Drug Administration, and Related Agencies" to the full Senate. As passed by the committee, the bill provides $229.2 mil. for CDRH, just $100,000 less than the President's budget request. In May, the House passed a version of the bill which shaved $476,000 off the President's request (1"The Gray Sheet" May 29, 2006, In Brief). Both versions of the budget are sufficient to enable continuation of the medical device user fee program...

COVID-19: WHO Supports Pooling Of Rights, MPP Includes Drugs and Tests

Intellectual property rights are in the spotlight again, after the World Health Organization and the Medicines Patent Pool announced initiatives to help ensure that all countries will be able to access products being developed for COVID-19.

'Hunker Down, Expect The Worst And Hope For The Best:' Investment Analyst Advises Medtech Businesses To Cut Costs

Maxim Jacobs, managing partner at Edison Investment Research urges medtech companies to be financially prudent as the COVID-19 pandemic worsens. Cancellations of routine surgeries are creating a huge strain on device businesses which could continue for months.

UsernamePublicRestriction

Register

MT023586

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel